期刊文献+

COX-2和Ki-67在膀胱移行细胞癌中的表达及其意义 被引量:2

Expression of COX-2 and Ki-67 in the Bladder Transitional Cell Carcinoma and the Significance
下载PDF
导出
摘要 目的:探讨环氧化酶-2(COX-2)和Ki-67在膀胱癌中的表达及其意义。方法:应用免疫组化S-P法检测52例膀胱移行细胞癌和12例正常膀胱组织中COX-2和Ki-67的表达。结果:COX-2和Ki-67在癌旁组织中均不表达,而在各级别的膀胱移行细胞癌中均有表达,二者差异有统计学意义(P<0.05)。结论:COX-2可以作为评估膀胱移行细胞癌细胞增殖的良好指标,COX-2和Ki-67的表达可以判断膀胱移行细胞癌的恶性程度。 Objective: To investigate the expression of COX-2 and Ki-67 in he bladder transitional cell carcinoma and the significance.Methods: The expression of COX-2 and Ki-67 was detected by S-P immunohistochemical technique in the bladder transitional cell carcinoma(n=52) and normal tissues(n=12).Results: The COX-2 and Ki-67 were not expressed in the all normal tissue,but the expression of COX-2 and Ki-67 could be detected in different grades of he bladder transitional cell carcinoma.The positive rate of COX-2 and Ki-67 expression in high grade group was significant higher than that in low grade group(P0.05).Conclusion: The expression level of COX-2 correlate significantly with proliferating activity ofhe bladder transitional cell carcinoma cell.The expression of COX-2 and Ki-67 Evaluate the malignancy degree of the bladder transitional cell carcinoma.
出处 《包头医学院学报》 CAS 2011年第1期8-9,共2页 Journal of Baotou Medical College
关键词 膀胱癌 环氧化酶-2 KI-67 Carcinoma of bladder COX-2 Ki-67 Immunohistochemistry
  • 相关文献

参考文献6

  • 1管晓翔,陈龙邦.环氧化酶-2在肿瘤发生中的作用机制[J].肿瘤防治杂志,2004,11(5):543-545. 被引量:5
  • 2Dannenberg A J, Mtorki NK, Boyle JO, et al. Cyclooxygenase -2:a pharmacological target for the preventi on of cancer [ J ]. Lancet Oneol,2001,2:544 - 551.
  • 3Shariat SF, Matsumoto K, Kim J, et al. Correlation of cycloox- ygenase- 2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder [ J ]. J Urol,2003,170 ( 3 ) : 985 - 989.
  • 4刘岩,高秀敏,李胜水,顾鑫,许华,张凤梅.COX-2和MMP-9在膀胱移行细胞癌中表达的意义及相关性[J].河北医药,2009,31(21):2881-2883. 被引量:4
  • 5Mellon K, Wright C, Kelly P, et al. Long - term outcome related to epidermal growth factor receptor status in bladder cancer [ J ]. J Urol, 1995,153 ( 3 Pt 2) :919 - 925.
  • 6Liu M, Lawson G, DelosM, et al. Predictive value of thefraction of cancer cells immunolabeled for proliferatingcell nu clearantigen orKi67 in biopsies ofhead and neckcarcinomas to identify lymph node metastasis : compari - son with clinical and radiologic examinations [ J ]. Head Neck, 2003,25 (4) :280 -288.

二级参考文献26

  • 1周洪澜,王医术,侯毅,李一雷,王心蕊,傅耀文.基质金属蛋白酶9在膀胱移行细胞癌中的表达及其意义[J].吉林大学学报(医学版),2005,31(2):309-310. 被引量:1
  • 2Xie G, Wang Y, Sharma M, et al. 5-Hydroxytryptamine-induced plasma extravasation in the rat knee joint is mediated by multiple prostaglandins[J]. Inflamm Res,2003,52(1):32-38.
  • 3Mitchell J A, Larkin S, Williams T J. Cyclooxygenase-2: regulation and relevance in inflammation[J].Biochem Pharmacol,1995,50(10):1535-1542.
  • 4Subbegowda R,Frommel T O. Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest[J]. Cancer Res,1998,58(13):2772-2776.
  • 5Ruegg C, Zaric J, Stupp R. et al. Non steroidal anti-inflammatory drugs and COX-2 inhibitors as anti-cancer therapeutics: hypes, hopes and reality[J]. Ann Med,2003,35(7):476-487.
  • 6Elder D J, Paraskeva C. Induced apoptosis in the prevention of colorectal cancer by non-steroidal anti-inflammatory drugs [J].Apoptosis,1999,4(5):365-372.
  • 7Morris C D, Armstrong G R, Bigley G, et al. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence[J]. Am J Gastroenterol,2001,96(4):990-996.
  • 8BakhleYS.COX-2 and cancer: a new approach to an old problem[J]. Br J Pharmacol,2001,134:1137-1150.
  • 9Kohno H, Nagasue N, Rahman M A. COX-2 - a target for preventing hepatic carcinoma? [J].Expert Opin Ther Targets,2002,6(4):483-490.
  • 10Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications[J]. Fundam Clin Pharmacol,1996,10(1):1-17.

共引文献7

同被引文献7

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部